Overall, what we are currently seeing is that weight loss GLP-1 shoppers are buying more compared to a year ago, while diabetes GLP-1 shoppers appear to be buying less over that same time period
The use of peptide dual agonists of the glucagon receptor (GCGR) and the glucagon-like peptide-1 receptor (GLP-1R) is one of the treatment options being researched and evaluated clinically for diabetes, obesity, and related conditions
Tingling Sensations Directly related to water retention is the potential for tingling or numbness in the extremities, often described as carpal tunnel-like symptoms
How you eat while taking them can significantly influence: Muscle preservation Metabolic health Inflammation levels Long-term outcomes Clinical trials of GLP-1 receptor agonists and tirzepatide show that a meaningful portion of weight loss can come from lean body mass (muscle) , particularly in the absence of targeted nutrition and resistance exercise strategies (Jastreboff et al., 2022
Crossing time zones
The intersection of these agents with the central nervous system provides a new lens for conceptualizing bipolar disorders complexity, highlighting the need for personalized, multi-faceted care